Medicinal chemistry and biological properties of non-imidazole histamine H3 antagonists

Mini-Reviews in Medicinal Chemistry

Volumn 4, Issue 9, 2004, Pages 979-992

  Cowart, Marlon ^a   Altenbach, Robert ^a   Black, Lawrence ^a   Faghih, Ramin ^a   Zhao, Chen ^a   Hancock, Arthur A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Antagonist; H3; Histamine; Inverse agonist; Non imidazole; Review

Indexed keywords

2 AMINO 1 [4 [3 (4 CYCLOPROPANECARBONYLPHENOXY)PROPYL] 1 PIPERAZINYL] 1 PROPANONE; A 923; ANTIHISTAMINIC AGENT; BENZOFURAN DERIVATIVE; BETAHISTINE; CIPROXIFAN; CLOBENPROPIT; CLOZAPINE; CYTOCHROME P450 INHIBITOR; DIMAPRIT; FUB 407; FUB 637; FUB 649; FUB 701; FUB 836; HISTAMINE H3 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; IODOPROXYFAN; KETOCONAZOLE; METHYLTRANSFERASE INHIBITOR; PHENCYCLIDINE; RWJ 20085; SABELUZOLE; TERFENADINE; THIOPERAMIDE; UCL 1972; UCL 2138; UCL 2173; UCL 2190; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC RHINITIS; ANIMAL DISEASE; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EPILEPSY; HUMAN; MENIERE DISEASE; NEUROLOGIC DISEASE; NONHUMAN; OBESITY; PAIN; PHARMACOPHORE; RECEPTOR AFFINITY; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING; VERTIGO;

EID: 4944229347     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557043403215     Document Type: Short Survey

References (113)

1. 3 Receptor: A Target for New Drugs. Leurs, R., Timmerman, H., Eds.; Pharmacochemistry Library v. 30; Elsevier: Amsterdam, the Netherlands, 1998.
2. Leurs, R.; Blandina, P.; Tedford, C.; Timmerman, H. Trends Pharmacol. Sci., 1998, 19, 177-183.
3. Stark, H.; Arrang, J. M.; Ligneau, X.; Garbarg, M.; Ganellin, C. R.; Schwartz, J. C.; Schunack, W. In Progress in Medicinal Chemistry, v. 38, King, F. D.; Oxford, A. W., Eds.; Elsevier Science; 2001: 38, 279-309.
4. Stark, H. Expert Opin. Ther. Patents, 2003, 13 851-865.
5. Timmerman, H. J. Med. Chem., 1990, 33, 4-11.
6. Hill, S. J.; Ganellin, C. R.; Timmerman, H.; Schwartz, J. C.; Shankley, N. P.; Young, J. M.; Schunack, W.; Levi, R.; Haas, H. L. Pharmacol. Rev., 1997, 49, 253-278.
7. Brown, R. E.; Stevens, D. R.; Haas, H. L. Prog. Neurobiol. 2001, 38, 279-308.
8. Lovenberg, T. W.; Roland, B. L.; Wilson, S. J.; Jiang, Z.; Jayashree, P.; Huvar, A.; Jackson, M. R.; Erlander, M. R. Mol. Pharm. 1999, 55, 1101-1107-1008.
9. Morisset, S.; Rouleau, A.; Ligneau, X.; Gbahou, F.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Schwartz, J.-C.; Arrang, J.-M. Nature, 2000, 408, 860-864.
10. Rouleau, A.; Ligneau, X.; Tardivel -Lacombe, J.; Morisset, S.; Gbahou, F.; Schwartz, J.-C.; Arrang, J.-M. Br. J. Pharmacol., 2002, 135, 383-392.
11. Ireland-Denny, L.; Parihar, A. S.; Miller, T. R.; Kang, C. H.; Krueger, K. M.; Esbenshade, T. E.; Hancock, A. A. Eur. J. Pharmacol., 2001, 433, 141-150.
12. Wullf, B.; Hastrup, S.; Rimvall, K. Eur. J. Pharmacol., 2002, 453, 33-41.
13. Yao, B. B.; Hutchins, C. W.; Carr, T. L.; Cassar, S.; Masters, J. N.; Bennani, Y. L.; Esbenshade, T. A.; Hancock, A. A. Neuropharmacology, 2003, 44, 773-786.
14. Ligneau, X.; Morisset, S.; Tardivel-Lacombe, J.; Gbahou, F.; Ganellin, C. R.; Stark, H.; Schunack, W.; Schwartz, J.-C.; Arrang, J.-M. Br. J. Pharmacol., 2000, 131, 1247-1250.
15. Lin, J. H.; Lu, A. Y. H. Clin. Pharmacokinet., 1998 35, 361-390.
16. Boxenbaum, H. J. Pharm. Pharmaceut. Sci., 1999, 2, 45-52.
17. Yang, R.; Hey, J. A.; Aslanian, R.; Rizzo, C. A. Pharmacology, 2002, 66, 128-135.
18. Kathmann, M.; Schlicker, E.; Gothert, M. Psychopharmacology (Berlin), 1994, 116, 464-484.
19. Walczynski, K.; Guryn, R.; Zuiderveld, O. P.; Timmerman, H. Il Farmaco, 1999, 54, 684-694.
20. Arrang, J.-M.; Garbarg, M.; Quach, T. T.; Trung Tuong, M. D.; Yeramian, E.; Schwartz, J.-C. Eur. J. Pharm., 1985, 111 73-84.
21. Schwartz, J.-D.; Arrang, J. M.; Garbarg, M.; Pollard, J. Agents Actions, 1990, 30, 13-23.
22. Arrang, J.-M.; Defontaine, N.; Schwartz, J.-C. Eur. J. Pharm., 1988, 157, 31-35.
23. Stark, H.; Hüls, A.; Ligneau, X.; Purand, K.; Pertz, H.; Arrang, J.-M.; Schwartz, J.-C.; Schunack, W. Arch. Pharm. Pharm. Med. Chem., 1998, 331, 211-218.
24. Stark, H.; Ligneau, X.; Arrang, J.-A.; Schwartz, J.-C.; Schunack, W. Bioorg. Med. Chem. Lett., 1998, 8, 2011-2016.
25. Pompni, S. A.; Gullo, V. P.; Horan, A. C.; Patel, M. G.; Coval, S. U.S. Patent 5,352,707; Oct. 4, 1994.
26. Ganellin, C. R.; Leurquin, F.; Piripitsi, A.; Arrang, J.-M.; Garbarg, M.; Ligneau, X.; Schunack, W.; Schwartz, J.-C. Arch. Pharm. Pharm. Med. Chem., 1998, 331, 395-404.
27. Meier, G.; Apelt, J.; Reichert, U.; Grassman, S.; Ligneau, X.; Elz, S.; Leurquin, F.; Ganellin, C. R.; Schwartz, J.-C.; Schunack, W.; Stark, H. Eur. J. Pharm. Sci., 2001, 13, 249-259.
28. Schwartz, J.-C.; Arrang, J.-M.; Garbarg, M.; Lecomte, J.-M.; Ligneau, X.; Schunack, W. G.; Stark, H.; Ganellin, C. R.; Leurquin, F.; Sigurd, E. Eur. Pat. appl. 0978512 Al; pub. Sept. 2, 2000; appl. WO 0006254, Sept. 10, 2000.
29. Liedtke, S.; Flau, K.; Kathmann, M.; Schlicker, E.; Stark; H.; Meier, G.; Schunack, W. Nauyn-Schmiedeberg's Arch. Pharm., 2003, 367, 43-50.
30. Sasse, A.; Ligneau, X.; Rouleau, A.; Elz, S.; Ganellin, C. R.; Arrang, J.-M.; Schwartz, J.-C.; Schunack W.; Stark, H. J. Med. Chem., 2002, 45, 4000-4010.
31. Leurquin, F.; Akinleminu, T. T.; Ganellin, C. R.; Halai, S.; Zhao, Y. H.; Stark, H.; Schunack, W.; Ligneau, X.; Schwartz, J.-C. Presented at the XXXII Annual Meeting of the European Histamine Research Society, May 7-11, 2003; Noordwijkerhout, the Netherlands.
32. Menge, W. M. P. B.; Enguehard, C.; Romeo, G.; Limmen, B.; Timmerman, H. the 15th EFMC Intl. Symp. Med. Chem. 1998, Edinburgh, Scotland.
33. Faghih, R.; Dwight, W.; Gentles, R.; Phelan, K.; Esbenshade, T. A.; Ireland, L.; Miller, T. R.; Kang, C.-H.; Fox, G. B.; Gopalakrishnan, S. M.; Hancock, A., Bennani, Y. L. Bioorg. Med. Chem. Lett., 2002, 12, 2031-2034.
34. Faghih, R.; Dwight, W.; Black, L.; Liu, H.; Gentles, R.; Phelan, K.; Esbenshade, T. A.; Ireland, L.; Miller, T.; Kang, C.-H.; Krueger, K. M.; Fox, G. B.; Hancock, A. A.; Bennani, Y. L. Bioorg. Med. Chem. Lett., 2002, 12, 2035-2037.
35. Esbenshade, T. A.; Krueger, K. M.; Miller, T. R.; Kang, C. H.; Denny, L. I.; Witte, D. G.; Yao, B. B.; Fox, G. B.; Faghih, R.; Bennani, Y. L.; Williams, M.; Hancock, A. A. J. Pharmacol. Exp. Ther. 2003, 305, 887-896.
36. Vasudevan, A.; Conner, S. E.; Gentles, R. G.; Faghih, R.; Liu, H.; Dwight, W.; Ireland, L.; Kang, C. H.; Esbenshade, T. A.; Bennani, Y. L.; Hancock, A. A. Bioorg. Med. Chem. Lett., 2002 12, 3055-3058.
37. Faghih, R.; Dwight, W.; Vasudevan, A.; Dinges, J.; Conner, S. E.; Esbenshade, T. A.; Bennani, Y. L.; Hancock, A. A. Bioorg. Med. Chem. Lett., 2002, 12, 3077-3079.
38. Curtis, M. P.; Dwight, W.; Fox, G. B.; Esbenshade, T. A.; Pan, J.-B.; Bennani, Y. L.; Hancock, A. A.; Faghih, R. Presented at the 225th ACS National Meeting, New Orleans, 2003; MEDI-240.
39. Faghih, R.; Dwight, W.; Pan, J. B.; Fox, G. B.; Krueger, K. M.; Esbenshade, T. A.; McVey, J. M.; Marsh, K.; Bennani, Y. L.; Hancock, A. A. Bioorg. Med. Chem. Lett., 2003, 13, 1325-1328.
40. Shah, C.; McAtee, L.; Breitenbucher, J. G.; Rudolph, D.; Li, X.; Lovenberg, T. W.; Mazur, C.; Wilson, S. J.; Carruthers, N. I. Bioorg. Med. Chem. Lett., 2002, 12, 3309-3312.
41. Chai, W.; Breitenbucher, J. G.; Kwok, A.; Li, X.; Wong, V.; Carruthers, N. I.; Lovenberg, T. W.; Mazur, C.; Wilson, S. J.; Axe, F. U.; Jones, T. K. Bioorg. Med. Chem. Lett., 2003, 13, 1767-1770.
42. Apodaca, R.; Carruthers, N. I.; Carson, J. R.; Chai, W.; Kwok, A. K.; Li, X.; Lovenberg, T. W.; Rudolph, D. A.; Shah, C. R. appl. WO 0224695 A2; pub. Mar. 28, 2002.
43. Apodaca, R.; Carruthers, N. I.; Dvorak, C.A.; Rudolph, D.A.; Shah, C. R.; Xiao, W. appl. WO 00212214; pub. Feb. 14, 2002.
44. Breitenbucher, J., G.; Carruthers, N. I.; Li, X.; McAtee, L. C.; Shah, C. R.; Wolin, R. L. appl. WO 0174815 A2; pub. Oct. 11, 2001.
45. Miko, T.; Ligneau, X.; Pertz, H. H.; Ganellin, C. R.; Arrang, J.-M.; Schwartz, J.-C.; Schunack, W.; Stark, H. J. Med. Chem., 2003, 46, 1523-1530.
46. Beavers, L.S.; Gadski, R.A.; Hipskind, P.A.; Lindsley, C.W.; Lobb, K.L.; Nixon, J.A.; Pickard, R.T.; Schaus, J.M.; Takakuwa, T.; Watson, B.M. appl. WO.02076925; pub. Oct. 3, 2002.
47. Apodaca, R.; Carruthers, N.A.; Dvorak, C.A.; Shah, C.R.; Xiao, W. appl. WO 0212190; pub. Feb. 14, 2002.
48. Hey, J. A.; Aslanian, R. G. appl. WO 02072093; pub. Sept. 19, 2002.
49. Rosenblum, S. B.; Zeng, Q.; Mutahi, M. W.; Aslanian, R. G.; Ting, P. C.; Shih, N.-Y.; Solomon, D. M.; Cao, J.; Vaccaro, H. A.; McCormick, K. D.; Baldwin, J. J.; Li, G. appl. WO 02072570; pub. Sept. 19, 2002.
50. Ting, P. C.; Lee, J. F.; Albanese, M. M.; Tom, W. C.; Solomon, D. M.; Aslanian, R.; Shih, N.-Y.; West, R. Bioorg. Med. Chem. Lett., 2002, 12, 2643-2646.
51. Goldstein, S.; Poissonnet, G.; Permentier, J.-G.; Lestage, P.; Lockhart, B. Eur. Patent appl. EP 1275647 A1; pub. Jan. 15, 2003.
52. Carruthers, N. I.; Li, X.; Lovenberg, T. appl. WO 0174810; pub. Oct. 11, 2001.
53. Apelt, J.; Ligneau, X.; Pertz, H. H.; Arrang, J.-M.; Ganellin, C. R.; Schwartz, J.-C.; Schunack, W.; Stark, H. J. Med. Chem., 2002, 45, 1128-1141.
54. Grassman, S.; Apelt, J.; Sippl, W.; Ligneau, X.; Pertz, H. H.; Zhao, Y. H.; Arrang, J.-M.; Ganellin, C. R.; Schwartz, J.-C.; Schunack, W.; Stark, H. Bioorg. Med. Chem. Lett., 2003, 11 2163-2174.
55. Menge, W. M. P. B.; Enguehard, C.; Romeo, G.; Limmen, B.; Timmerman, H. the 15th EFMC Intl. Symp. Med. Chem. 1998, Edinburgh, Scotland, UK.
56. Walczynski, K.; Guryn, R.; Zuiderveld, O. P.; Timmerman, H. Arch. Pharm. Pharm. Med. Chem., 1999, 332, 389-398.
57. Walczynski, K.; Guryn, R.; Zuiderveld, O. P.; Timmerman, H. Il Farmaco, 1999, 54, 684-694.
58. Linney, I. D.; Buck, I. M.; Harper, E. A.; Kalindjian, B.; Perther, M. J.; Shankley, N. P.; Watt, G. F.; Wright, P. T. J. Med. Chem., 2000, 43, 2362-2370.
59. Turner, S. C.; Esbenshade, T. A.; Bennani, Y. L.; Hancock, A. A. Bioorg. Med. Chem. Lett., 2003, 13, 2131-2135.
60. Aslanian, R. G.; Shih, N.-Y.; Ting, P. C.; Berlin, M. Y.; Rosenblum, S. B.; McCormick, K. D.; Tom, W. C.; Boyce, C. W.; Mangiaracina, P.; Mutahi, M. W.; Piwinski, J. J. appl. WO 0232893 A2; pub. Apr. 25, 2002.
61. Dörwald, F. Z., Hohlweg, R. appl. WO 0324928 A2; pub. Mar. 27, 2003.
62. Dörwald, F. Z.; appl. WO 0324929 A1; pub. Mar. 27, 2003
63. Dörwald, F. Z.; appl. WO 0331432 A1; pub. Apr. 17, 2003
64. Rimvall, K.; Malmlöf, K.; Cremers, H.; Zaragoza, F.; Wulff, B. S.; Raun, K.; Romer, J.; deBeun, R.; Golozoubova, V.; Refsgaard, H.; Johansen, P. B. Presented at the XXXII Annual Meeting of the European Histamine Research Society, May 7-11, 2003; Noordwijkerhout, the Netherlands.
65. Zaragoza, F.; Stephensen, H.; Bywater, R. P.; Hohlweg, R.; Moller, Knudsen, S. M.; Pettersson, I. V.; Pridal, L.; Refsgaard, H.; Wulff, B. S.; Rimvall, K. Presented at the XXXII Annual Meeting of the European Histamine Research Society, May 7-11, 2003; Noordwijkerhout, the Netherlands.
66. Meier, G.; Ligneau, X.; Pertz, H. H.; Ganellin, C. R.; Schwartz, J.-C.; Schunack, W.; Stark, H. Bioorg. Med. Chem., 2002, 10, 2535-2542.
67. Lazewska, D.; Kiec-Kononowicz, K.; Pertz, H. H.; Elz, S.; Stark, H.; Schunack, W. Pharmazie, 2002, 57, 791-795.
68. Cowart, M. D.; Bennani, Y. L.; Faghih, R.; Gfesser, G. A.; Black, L. A. U. S. Patent appl. US 02169188 A1; pub. Nov. 14, 2002.
69. Cowart, M.; Faghih, R.; Gfesser, G.; Curtis, M.; Pratt, J. K.; Bennani, Y. L.; Fox, G. B.; Esbenshade, T. A.; Hancock, A. A. Presented at the XXXII Annual Meeting of the European Histamine Research Society, May 7-11, 2003; Noordwijkerhout, the Netherlands.
70. Hough, L. B. Mol. Pharm., 2001, 59, 415-419.
71. Wieland, K.; Bongers, G.; Yamamoto, Y.; Hashimoto, T.; Yamatodani, A.; Menge, W. M. B. P.; Timmerman, H.; Lovenberg, T. W.; Leurs, R. Journal of Pharmacology and Experimental Therapeutics, 2001, 299, 908-914.
72. Hancock, A. A.; Bush, E. N.; Shapiro, R.; Nuss, M.; Segel, V.; Wilcox, D. M.; Droz, B.; Dickinson, R. W.; Jacobson, P. B.; Bennani, Y. L.; Esbenshade, T. A.; Faghih, R. Presented at the 225th ACS National Meeting, New Orleans, March 23-27, 2003, MEDI-003.
73. Hancock, A. A.; Fox, G. B. In Drugs that target histaminergic receptors, Cognitive Enhancing Drugs, Ed. J.J. Buccafusco; Birkhauser Verlag, Basel, 2004, pp. 97-114.
74. Chazot, P. L.; Hann, V. Current Opin. Investigational Drugs, 2001, 2, 1428-1431.
75. Murakami, K.; Yokoyama, H.; Onodera, K.; Iinuma, K.; Watanabe, T., Methods Find. Exp. Clin. Pharmacol., 1995, 17(Suppl. C), 70-3.
76. Farzin, D.; Asghari, L.; Nowrouzi, M. Pharmacol. Biochem. Behav., 2002, 72, 751-760.
77. Cannon, K. E.; Nalwalk, J. W.; Stadel, R.; Rice, F. L.; Ge, P.; Lawson, D.; Silos-Santiago, I.; Hann, V.; Chazot, P.; Hough, L. B. Presented at the XXXII Annual Meeting of the European Histamine Research Society, May 7-11, 2003; Noordwijkerhout, the Netherlands.
78. Perez-Garcia, C.; Morales, L.; Cano, M. V.; Sancho, I.; Alguacil, L. F. Psychopharmacology, 1999, 142, 215-220.
79. Lamberti, C.; Ipponi, A.; Bartolini, A.; Schunack, W.; Malmberg-Aiello, P. Br. J. Pharmacol., 1998, 123, 1331-1336.
80. Pan, J. B.; O'Neill, A. B.; Hancock, A. A.; Sullivan, J. P.; Brioni, J. D. Meth. Find. Exp. Clin. Pharmacol., 1998, 20 771-777.
81. O'Neill, A. B.; Pan, J. B.; Sullivan, J. P.; Brioni, J. D. Meth. Find. Exp. Clin. Pharmacol., 1999, 21, 285-289.
82. Lacour, M.; Sterkers, O. CNS Drugs, 2001, 15 853-870.
83. Arrang, J. M.; Garbarg, M.; Quach, T. T.; Trung Tuong, M. D.; Yeramian, E.; Schwartz, J. -C. Eur. J. Pharm., 1985, 111 73-84.
84. McLeod, R. L.; Egan, R. W.; Cuss, F. M.; Bolser, D. C.; Hey, J. A. Prog. Resp. Res., 2001, 31, 133-136.
85. McLeod, R. L.; Mingo, G. G.; Herczku, C.; DeGennaro-Culver, F.; Kreutner, W.; Egan, R. W.; Hey, J. A. Amer. J. Rhinology, 1999, 13, 391-9.
86. McLeod, R. L.; Rizzo, C. A.; West, R. E. Jr.; Aslanian, R.; McCormick, K.; Bryant, M.; Hsieh, Y.; Korfmacher, W.; Mingo, G. G.; Varty, L.; Williams, S. M.; Shih, N.-Y.; Egan, R. W.; Hey, J. A. J. Pharm. Exp. Therap., 2003, 305, 1037-1044.
87. Sakata, T.; Yoshimatsu, H.; Kurokawa, M. Nutrition, 1997, 13, 403-411.
88. Sakata, T.; Ookuma, K.; Fujimoto, K.; Fukagawa, K.; Yoshimatsu, H. Brain Res. Bull., 1991, 27, 371-375.
89. Sakata, T.; Yoshimatsu, H. Methods & Findings in Exp. & Clin. Pharmacol., 1995, 17 Suppl. C, 51-56.
90. Bjenning, C.; Liu, W.; Rimvall, K. International Congress Series, 2001, 1224 (Histamine Research in the New Millennium), 451-452.
91. Yates, S. L.; Powlowski, G. P.; Babu, J. S.; Rajagopalan, R.; Wawro, W. J.; Tedford, C. E. Presented at the 225th ACS National Meeting, New Orleans, March 23-27, 2003, MEDI-002.
92. Yates, S. L.; Tedford, C. E.; Brunden, K. R. U. S. Patent appl. US 030069295 A1; April 10, 2003.
93. Tsuda, K.; Yoshimatsu, H.; Niijima, A., Chiba, S.; Okeda, T.; Sakata T. Exp. Biol. & Med. 2002, 227, 208-213.
94. Attoub, S; Moizo, L.; Sobhani, I.; Laigneau, J. P.; Lewin, M. J. M.; Bado, A. Life Sci., 2001, 69, 469-478.
95. Itoh, E.; Fujimiya, M.; Inui A. Regulatory Peptides, 1998, 75-76, 373-376.
96. Toyota, H.; Dugovic, C.; Koehl, M.; Laposky, A.D.; Weber, C.; Ngo, K.; Wu, Y.; Lee, D. H.; Yanai, K.; Sakurai, E.; Watanabe, T.; Liu, C.; Chen, J.; Barbier, A. J.; Turek, F. W.; Fung-Leung, W.-P.; Lovenberg, T. W. Mol. Pharmacol., 2002, 62, 389-397.
97. Takahashi, K.; Suwa, H.; Ishikawa T.; Kotani, H. J. Clin. Invest., 2002, 110, 1791-1799.
98. Schwartz, J.-C. Ann. Rev. Pharmacol. Toxicol., 1977 17, 325-339.
99. Monti, J. M.; Jantos, H.; Boussard, M.; Altier, H.; Orellana, C.; Olivera, S. Eur. J. Pharmacol., 1991, 205, 283-7.
100. Lin, J. S.; Sakai, K.; Vanni-Mercier, G.; Arrang, J. M.; Garbarg, M.; Schwartz, J. C.; Jouvet, M. Brain Res., 1990, 523, 325-30.
101. Prast, H.; Argyriou, A.; Philippu, A. Brain Res., 1996, 734, 316-318.
102. Flood, J. F.; Uezu, K.; Morley, J. E. Psychopharmacology 1998, 140, 279-284.
103. Chen, Z.; Sugimoto, Y.; Kamei, C. J. Brain Sci., 1997, 23, 225-240.
104. Orsetti, M.; Ferretti, C.; Gamalero, S. R.; Ghi, P. Psychopharmacology, 2002, 159, 133-137.
105. Orsetti, M.; Ghi, P.; Di Carlo, G. Behav. Brain Res., 2001, 124, 235-242.
106. Ghi, P.; Ferretti, C.; Orsetti, M. Inflammation Research 2001, 50 (Suppl. 2), S78-S79.
107. Onodera, K.; Miyazaki, S.; Imaizumi, M.; Stark, H.; Schunack, W. Naunyn-Schmiedeberg's Arch. Pharmcol., 1998, 357, 508-513.
108. 3 Receptor: A Target for New Drugs. Leurs, R.; Timmerman, H., Eds.; Pharmacochemistry Library v. 30; pp. 269-286; Elsevier: Amsterdam, the Netherlands, 1998.
109. Fox, G. B.; Pan, J. B.; Esbenshade, T. A.; Bennani, Y. L.; Black, L. A.; Faghih, R.; Hancock, A. A.; Decker, M. W. Behavioural Brain Research, 2002, 131, 151-161.
110. Fox, G. B.; Pan, J. B.; Radek, R. J.; Lewis, A. M.; Bitner, R. S.; Esbenshade, T. A.; Faghih, R.; Bennani, Y. L.; Williams, M.; Yao, B. B.; Decker, M. W.; Hancock, A. A. J. Pharm. Exp. Therapeutics, 2003, 305, 897-908.
111. Baranowski, J. L.; Krueger, K. M.; Miller, T. M.; Kang, C. H.; Witte, D. G.; Yao, B. B.; Faghih, R.; Bennani, Y. L.; Dwight, W.; Esbenshade, T. A.; Hancock. A. A. FASEB J., 2003, 17, 3749.
112. Hancock, A. A.; Fox, G. B.; Pan, J. B.; Calzadilla, S.; Reinhart, G. A.; Dwight, W.; Faghih, R.; Bennani, Y.; Esbenshade, T. FASEB J., 2003, 17, 3701.
113. Fox, G. B.; Pan, J. B.; Komater, V.; Lewis, A.; Browman, K.; Buckley, M.; Curzon, P.; Radek, R.; Rueter, L.; Zhang, M.; Faghih, R.; Esbenshade, T. A.; Cowart, M.; Decker, M. W.; Hancock, A. A. Presented at the XXXII Annual Meeting of the European Histamine Research Society, May 7-11, 2003; Noordwijkerhout, the Netherlands.